Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl-patients with two mutations at a second BBS locus - Badano, JL; Kim, JC; Hoskins, BE (Hum Mol Genet, 2003)
et al.